Abstract
2012 American Society of Hematology Annual Meeting
Atlanta, GA, USA, 8–11 December 2012
The American Society of Hematology Annual Meeting includes physicians, scientists, administrators, medical students, graduate students, allied health professionals and exhibitors. This year’s meeting was held in Atlanta, GA, USA. Presentations included a wide variety of topics in benign and malignant hematology.
Financial & competing interests disclosure
RM Stone serves as an ad hoc consultant for Teva, Ltd, Celgene, Ltd, Amgen, Inc. and Sunesis Pharmaceuticals, Inc. and has received research support from Novartis, Ltd. The author has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
No writing assistance was utilized in the production of this manuscript.